Pharma BD Deal Intelligence
Takeda Pharmaceutical Company Ltd. / Ariad Pharmaceuticals
2003 · Acquisition/Merger · $5.2B · Complete
Announcement Sentiment
88
Strongly positive
Outcome Score
77
Worked — the deal delivered on its rationale.
Takeda acquired Ariad for $5.2B for oncology and hematology divisions.
Key facts
- Announced Aug 17, 2003
- Closed Feb 16, 2017
- Deal value $5.2B
- Deal type Acquisition/Merger
- Therapeutic area Oncology
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals